Katina Dorton
Director · 6 filings · Latest: Jul 15, 2026
Fulcrum Therapeutics, Inc.
Keenova Therapeutics plc
Prelude Therapeutics Inc
TScan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NONE | Katina Dorton | Director | Jun 2, 2026 | Option Exercise | — | 4,882 | — | 7,387 |